» Articles » PMID: 22977616

Adiponectin Suppresses Endoplasmic Reticulum Stress in Nonalcoholic Steatohepatitis

Overview
Journal Exp Ther Med
Specialty Pathology
Date 2012 Sep 15
PMID 22977616
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

In this study, we examined whether adiponectin suppresses endoplasmic reticulum (ER) stress in nonalcoholic steatohepatitis (NASH) using male transgenic mice expressing nSREBP-1c in adipose tissue, nSREBP-1c/adiponectin double-transgenic mice expressing human adiponectin in the liver, and wild-type male mice as the control. Histological findings similar to those observed in liver specimens from patients with NASH were observed in the livers from the nSREBP-1c transgenic mice at 30 weeks of age. By contrast, the NASH-like liver histology was markedly attenuated in age-matched nSREBP-1c/adiponectin double-transgenic mice. The nSREBP-1c/adiponectin double-transgenic mice showed human adiponectin production in the liver and a restored circulating human adiponectin level. Human adiponectin messenger ribonucleic acid (mRNA) expression in the liver was identified in the nSREBP-1c/adiponectin double-transgenic mice, but adiponectin receptor 1 and 2 mRNA expression in the liver was normal. TNFα mRNA was decreased in the liver of the nSREBP-1c/adiponectin double-transgenic mice compared with the nSREBP-1c transgenic mice. The protein expressions of X-box-binding protein-1, activating transcription factor 4, acetyl-CoA carboxylase, TNFα and NFκB were down-regulated in liver tissues from the nSREBP-1c/adiponectin double-transgenic mice. Mouse adiponectin and activating transcription factor 6 expressions were almost the same in the three groups. Post-load plasma glucose levels were significantly lower in the nSREBP-1c/adiponectin double-transgenic mice compared with the nSREBP-1c transgenic mice. These results indicate that adiponectin expressed in the liver suppresses ER stress and attenuates hepatic steatosis, inflammation and insulin resistance in NASH. Adiponectin may open the way to novel therapies for human NASH.

Citing Articles

The effect and application of adiponectin in hepatic fibrosis.

Chen T, Yang W, Dong R, Yao H, Sun M, Wang J Gastroenterol Rep (Oxf). 2024; 12:goae108.

PMID: 39737222 PMC: 11683834. DOI: 10.1093/gastro/goae108.


Mesenchymal Stem Cell-Derived Exosomes Attenuate Hepatic Steatosis and Insulin Resistance in Diet-Induced Obese Mice by Activating the FGF21-Adiponectin Axis.

Kim B, Ronaldo R, Kweon B, Yoon S, Park Y, Baek J Int J Mol Sci. 2024; 25(19).

PMID: 39408777 PMC: 11476820. DOI: 10.3390/ijms251910447.


The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future.

Watanabe Y, Tsuchiya A, Terai S Clin Mol Hepatol. 2020; 27(1):70-80.

PMID: 33317249 PMC: 7820202. DOI: 10.3350/cmh.2020.0194.


Serum omentin and vaspin levels in cirrhotic patients with and without portal vein thrombosis.

Kukla M, Waluga M, Zorniak M, Berdowska A, Wosiewicz P, Sawczyn T World J Gastroenterol. 2017; 23(14):2613-2624.

PMID: 28465646 PMC: 5394525. DOI: 10.3748/wjg.v23.i14.2613.


Pathobiology of liver fibrosis: a translational success story.

Lee Y, Wallace M, Friedman S Gut. 2015; 64(5):830-41.

PMID: 25681399 PMC: 4477794. DOI: 10.1136/gutjnl-2014-306842.


References
1.
Colgan S, Tang D, Werstuck G, Austin R . Endoplasmic reticulum stress causes the activation of sterol regulatory element binding protein-2. Int J Biochem Cell Biol. 2007; 39(10):1843-51. DOI: 10.1016/j.biocel.2007.05.002. View

2.
Wek R, Anthony T . Obesity: stressing about unfolded proteins. Nat Med. 2010; 16(4):374-6. DOI: 10.1038/nm0410-374. View

3.
Lee A, Glimcher L . Intersection of the unfolded protein response and hepatic lipid metabolism. Cell Mol Life Sci. 2009; 66(17):2835-50. PMC: 3096022. DOI: 10.1007/s00018-009-0049-8. View

4.
Nakayama H, Otabe S, Yuan X, Ueno T, Hirota N, Fukutani T . Effects of adiponectin transgenic expression in liver of nonalcoholic steatohepatitis model mice. Metabolism. 2009; 58(7):901-8. DOI: 10.1016/j.metabol.2009.03.004. View

5.
Rutkowski D, Wu J, Back S, Callaghan M, Ferris S, Iqbal J . UPR pathways combine to prevent hepatic steatosis caused by ER stress-mediated suppression of transcriptional master regulators. Dev Cell. 2008; 15(6):829-40. PMC: 2923556. DOI: 10.1016/j.devcel.2008.10.015. View